HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Flavio Arienti Selected Research

vitespin

8/2006A phase II trial of vaccination with autologous, tumor-derived heat-shock protein peptide complexes Gp96, in combination with GM-CSF and interferon-alpha in metastatic melanoma patients.
10/2002Vaccination of metastatic melanoma patients with autologous tumor-derived heat shock protein gp96-peptide complexes: clinical and immunologic findings.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Flavio Arienti Research Topics

Disease

14Neoplasms (Cancer)
01/2021 - 10/2002
11Melanoma (Melanoma, Malignant)
01/2021 - 03/2002
1B-Cell Lymphoma (Lymphoma, B Cell)
02/2024
1Hematologic Neoplasms (Hematological Malignancy)
09/2017
1Sarcoma (Soft Tissue Sarcoma)
01/2017
1Dermatofibrosarcoma
01/2017
1Graft vs Host Disease (Graft-Versus-Host Disease)
06/2015
1Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
06/2015
1Nausea
04/2015
1Pain (Aches)
04/2015
1Pruritus (Itching)
04/2015
1Respiratory Insufficiency (Respiratory Failure)
04/2015
1Vomiting
04/2015
1Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
06/2014
1Colorectal Neoplasms (Colorectal Cancer)
11/2008
1Human Influenza (Influenza)
04/2006
1Adenocarcinoma
05/2004
1Neuroblastoma
10/2003

Drug/Important Bio-Agent (IBA)

7AntigensIBA
06/2009 - 03/2002
5Peptides (Polypeptides)IBA
08/2006 - 10/2003
4CytokinesIBA
01/2016 - 03/2002
3Heat-Shock Proteins (Heat-Shock Protein)IBA
11/2008 - 10/2002
3VaccinesIBA
08/2006 - 03/2002
3MART-1 AntigenIBA
05/2006 - 05/2004
2L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
01/2021 - 01/2016
2MicroRNAs (MicroRNA)IBA
12/2018 - 01/2016
2Interleukin-2 (IL2)IBA
06/2009 - 03/2002
2HLA-A*02:01 antigenIBA
11/2008 - 05/2004
2EnzymesIBA
08/2006 - 10/2003
2Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
08/2006 - 05/2004
2vitespinIBA
08/2006 - 10/2002
2Recombinant ProteinsIBA
04/2006 - 10/2003
2AntibodiesIBA
10/2003 - 03/2002
2Immunoglobulin G (IgG)IBA
10/2003 - 03/2002
1Chimeric Antigen ReceptorsIBA
02/2024
1Biomarkers (Surrogate Marker)IBA
01/2021
1Immune Checkpoint InhibitorsIBA
12/2018
1Indicators and Reagents (Reagents)IBA
12/2018
1Imatinib Mesylate (Gleevec)FDA Link
01/2017
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2016
1VemurafenibIBA
01/2016
1Toll-Like Receptors (Toll-Like Receptor)IBA
07/2014
1Interleukin-6 (Interleukin 6)IBA
07/2014
1Interleukin-15 (Interleukin 15)IBA
06/2009
1Monoclonal AntibodiesIBA
06/2009
1Transforming Growth Factor beta1 (TGF beta 1)IBA
06/2009
112- (4'- azido- 2'- nitrophenoxy)dodecanoyl- coenzyme AIBA
11/2008
1EpitopesIBA
11/2008
1Glucose (Dextrose)FDA LinkGeneric
11/2008
1Cell-Free Nucleic AcidsIBA
06/2007
1Interferon-alpha (Interferon Alfa)IBA
08/2006
1SurvivinIBA
04/2006
1Proteins (Proteins, Gene)FDA Link
04/2006
1Cancer VaccinesIBA
04/2006
1Neoplasm Antigens (Tumor Antigens)IBA
10/2003
1Melanoma-Specific AntigensIBA
10/2002
1Immunoglobulin M (IgM)IBA
03/2002
1Complement System Proteins (Complement)IBA
03/2002
1Interleukin-4 (Interleukin 4)IBA
03/2002

Therapy/Procedure

4Therapeutics
01/2021 - 10/2003
2Immunotherapy
12/2018 - 01/2017
1Photopheresis
06/2015
1Cytoreduction Surgical Procedures
04/2015
1Drug Therapy (Chemotherapy)
04/2015
1Epidural Analgesia
04/2015
1Salvage Therapy
06/2014
1Anesthesia
07/2006